4 Healthcare Stock Stories for Tuesday Investment Wellness

Sanofi and Transgene have reached a collaboration agreement for the creation of a new state-of-the-art industrial platform focused on the output of immunotherapy products including Transgene’s therapeutic products. The platform will be established on Genzyme Polyclonals site in the Lyon-Gerland area for an investment amount of €10 million equally financed by Sanofi and Transgene, but the Platform will remain Sanofi’s exclusive property.